BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AZD0516 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AZD0516\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07181161-11144@assetmemo.bio
DTSTAMP:20261121T005555Z
DTSTART;VALUE=DATE:20290118
DTEND;VALUE=DATE:20290119
SUMMARY:AZD0516: Phase 1/2 readout est. (NCT07181161)
DESCRIPTION:AZD0516\, phase 1/2\, Prostate Cancer.\nStudy: Study of AZD0516
  as Monotherapy and in Combination in Participants With Metastatic Prostat
 e Cancer\nEstimated primary completion: 18 January 2029. This is a Clinica
 lTrials.gov estimate\, not a confirmed readout date\, and it can move.\nDr
 ug page: https://assetmemo.bio/drug/azd0516#upcoming-events\nRegistry reco
 rd: https://clinicaltrials.gov/study/NCT07181161
URL:https://assetmemo.bio/drug/azd0516#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
